BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7980332)

  • 1. Enhanced cerebral blood flow in acute mountain sickness.
    Baumgartner RW; Bärtsch P; Maggiorini M; Waber U; Oelz O
    Aviat Space Environ Med; 1994 Aug; 65(8):726-9. PubMed ID: 7980332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study.
    Baumgartner RW; Spyridopoulos I; Bärtsch P; Maggiorini M; Oelz O
    J Appl Physiol (1985); 1999 May; 86(5):1578-82. PubMed ID: 10233120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery.
    Lysakowski C; Von Elm E; Dumont L; Junod JD; Tassonyi E; Kayser B; Tramèr MR
    Clin Sci (Lond); 2004 Mar; 106(3):279-85. PubMed ID: 14572304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral arterial desaturation is further exacerbated by exercise in adolescents with acute mountain sickness.
    Major SA; Hogan RJ; Yeates E; Imray CH
    Wilderness Environ Med; 2012 Mar; 23(1):15-23. PubMed ID: 22441084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high altitude exposure on cerebral hemodynamics in normal subjects.
    Van Osta A; Moraine JJ; Mélot C; Mairbäurl H; Maggiorini M; Naeije R
    Stroke; 2005 Mar; 36(3):557-60. PubMed ID: 15692117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of residence at moderate versus low altitude on reducing acute mountain sickness in men following rapid ascent to 4300 m.
    Staab JE; Beidleman BA; Muza SR; Fulco CS; Rock PB; Cymerman A
    High Alt Med Biol; 2013 Mar; 14(1):13-8. PubMed ID: 23537255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into ocular blood flow at very high altitudes.
    Bosch MM; Merz TM; Barthelmes D; Petrig BL; Truffer F; Bloch KE; Turk A; Maggiorini M; Hess T; Schoch OD; Hefti U; Sutter FK; Pichler J; Huber A; Landau K
    J Appl Physiol (1985); 2009 Feb; 106(2):454-60. PubMed ID: 19057000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AltitudeOmics: cerebral autoregulation during ascent, acclimatization, and re-exposure to high altitude and its relation with acute mountain sickness.
    Subudhi AW; Fan JL; Evero O; Bourdillon N; Kayser B; Julian CG; Lovering AT; Panerai RB; Roach RC
    J Appl Physiol (1985); 2014 Apr; 116(7):724-9. PubMed ID: 24371013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional differences in the cerebral blood flow velocity response to hypobaric hypoxia at high altitudes.
    Feddersen B; Neupane P; Thanbichler F; Hadolt I; Sattelmeyer V; Pfefferkorn T; Waanders R; Noachtar S; Ausserer H
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1846-51. PubMed ID: 26082017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of cerebral blood flow regulation to acute mountain sickness.
    Otis SM; Rossman ME; Schneider PA; Rush MP; Ringelstein EB
    J Ultrasound Med; 1989 Mar; 8(3):143-8. PubMed ID: 2657093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right temporal cerebral dysfunction heralds symptoms of acute mountain sickness.
    Feddersen B; Ausserer H; Neupane P; Thanbichler F; Depaulis A; Waanders R; Noachtar S
    J Neurol; 2007 Mar; 254(3):359-63. PubMed ID: 17345040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure is not associated with acute mountain sickness.
    Cushing T; Paterson R; Haukoos J; Harris NS
    High Alt Med Biol; 2013 Dec; 14(4):342-5. PubMed ID: 24377341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cerebral blood flow and vasoreactivity to CO2 measured by arterial spin labeling after 6days at 4350m.
    Villien M; Bouzat P; Rupp T; Robach P; Lamalle L; Troprès I; Estève F; Krainik A; Lévy P; Warnking JM; Verges S
    Neuroimage; 2013 May; 72():272-9. PubMed ID: 23384523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary gas exchange in acute mountain sickness.
    Sutton JR; Bryan AC; Gray GW; Horton ES; Rebuck AS; Woodley W; Rennie ID; Houston CS
    Aviat Space Environ Med; 1976 Oct; 47(10):1032-7. PubMed ID: 985274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral vasomotor reactivity at high altitude in humans.
    Jansen GF; Krins A; Basnyat B
    J Appl Physiol (1985); 1999 Feb; 86(2):681-6. PubMed ID: 9931208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness.
    Schommer K; Wiesegart N; Dehnert C; Mairbäurl H; Bärtsch P
    High Alt Med Biol; 2011; 12(4):323-7. PubMed ID: 22206557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic response to moderate altitude exposure among infants and young children.
    Yaron M; Niermeyer S; Lindgren KN; Honigman B; Strain JD; Cairns CB
    High Alt Med Biol; 2003; 4(1):53-9. PubMed ID: 12713712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sea-level assessment of dynamic cerebral autoregulation predicts susceptibility to acute mountain sickness at high altitude.
    Cochand NJ; Wild M; Brugniaux JV; Davies PJ; Evans KA; Wise RG; Bailey DM
    Stroke; 2011 Dec; 42(12):3628-30. PubMed ID: 21960569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course variations in the mechanisms by which cerebral oxygen delivery is maintained on exposure to hypoxia/altitude.
    Imray C; Chan C; Stubbings A; Rhodes H; Patey S; Wilson MH; Bailey DM; Wright AD;
    High Alt Med Biol; 2014 Apr; 15(1):21-7. PubMed ID: 24559404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of acute mountain sickness by monitoring arterial oxygen saturation during ascent.
    Karinen HM; Peltonen JE; Kähönen M; Tikkanen HO
    High Alt Med Biol; 2010; 11(4):325-32. PubMed ID: 21190501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.